Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
Sara Al‐Khawaga, Essam M. Abdelalim
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
Bruno Andrade, Sérgio Siqueira, Wagner Rodrigues de Assis Soares, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 700-700
Open Access | Times Cited: 401
Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?
Meng Kou, Li Huang, Jinjuan Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 304
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100794-100794
Open Access | Times Cited: 264
Advances in mesenchymal stem cell exosomes: a review
Yaya Tang, Yan Zhou, Hong-jun LI
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 229
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 152
Extracellular vesicles in the pathogenesis and treatment of acute lung injury
Qian Hu, Shu Zhang, Yue Yang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 92
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
Elham Oveili, Somayeh Vafaei, Haniyeh Bazavar, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 77
Advances in Mesenchymal Stem Cell Therapy for Immune and Inflammatory Diseases: Use of Cell-Free Products and Human pluripotent Stem Cell-Derived Mesenchymal Stem Cells
Li‐Tzu Wang, Ko‐Jiunn Liu, Huey‐Kang Sytwu, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 9, pp. 1288-1303
Open Access | Times Cited: 90
BMSC‐Derived Exosomes Ameliorate LPS‐Induced Acute Lung Injury by miR‐384‐5p‐Controlled Alveolar Macrophage Autophagy
Xuan Liu, Chengjin Gao, Yang Wang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 81
MSC-Derived exosomes suppress colorectal cancer cell proliferation and metastasis via miR-100/mTOR/miR-143 pathway
Babak Jahangiri, Mohammad Khalaj‐Kondori, Elahe Asadollahi, et al.
International Journal of Pharmaceutics (2022) Vol. 627, pp. 122214-122214
Closed Access | Times Cited: 48
Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases
Yuguo Yuan, Jialin Wang, Yaxin Zhang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3177-3210
Open Access | Times Cited: 38
Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery
Yasunari Matsuzaka, Ryu Yashiro
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 707-707
Open Access | Times Cited: 13
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 2, pp. 341-356
Open Access | Times Cited: 54
Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects
Vamika Karn, Shaista Ahmed, Lung‐Wen Tsai, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1373-1373
Open Access | Times Cited: 52
Stem Cell-Derived Exosome as Potential Therapeutics for Microbial Diseases
Somayeh Keshtkar, Maryam Kaviani, Saeede Soleimanian, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 36
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis
Asmaa A. Ashour, Amal H. El‐Kamel, Radwa A. Mehanna, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3270-3280
Open Access | Times Cited: 36
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 35
Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control
Avinash Naraiah Mukkala, Mirjana Jerkic, Zahra Khan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15788-15788
Open Access | Times Cited: 15
Deciphering the Heterogeneity Landscape of Mesenchymal Stem/Stromal Cell‐Derived Extracellular Vesicles for Precise Selection in Translational Medicine
Ye Li, Yin‐Hsueh Chen, Bing‐Yun Liu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 15
Open Access | Times Cited: 13
Emerging role of mesenchymal stem cells-derived extracellular vesicles in vascular dementia
Ziying Liu, Lin Cheng, Lushun Zhang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
Eleonore Fröhlich
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 32
The Antisenescence Effect of Exosomes from Human Adipose-Derived Stem Cells on Skin Fibroblasts
Jian Guo, Pijun Yu, Dong-Qin Yang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 20
How Does Long-COVID Impact Prognosis and the Long-Term Sequelae?
Carolina Baroni, Jorge Potito, María Eugenia Perticone, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1173-1173
Open Access | Times Cited: 11
New perspectives on the treatment of diabetic nephropathy: Challenges and prospects of mesenchymal stem cell therapy
Canyu Chen, Bo Xu, Weiyi Li, et al.
European Journal of Pharmacology (2025), pp. 177543-177543
Closed Access
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Birbal Singh, Gorakh Mal, Vinod Verma, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top